πŸ“Š This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: N2 Biomedical

1.1 - Company Overview

N2 Biomedical Logo

N2 Biomedical

Headquarter: United States
Founded: 20XXπŸ”’
Employees: 100-500πŸ”’
🌐 Website

Company description

  • Provider of coating, anodizing, and printing services for medical devicesβ€”including guidewires, core wires, hypo tubes, and forming mandrelsβ€”for global healthcare and medical device companies. Collaborates from concept to commercialization, offering flexible prototype work and high-volume production.

Products and services

πŸ”’

Key contacts

πŸ”’
πŸ”’

Financial details

πŸ”’

1.2 - Competitors and similar companies to N2 Biomedical

Nano-C Logo

Nano-C

HQ: United States Website
  • Description: Provider of nanostructured carbon materials for energy and electronics, including carbon fullerenes and derivatives, single-walled carbon nanotubes, and fullerene-based electron acceptors for OPV. Also offers functionalized fullerenes for biopharmaceuticals and CNT-based NRAM delivering high-density, high-speed nonvolatile memory, serving applications in displays, sensors, semiconductor manufacturing, and energy storage.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nano-C company profile β†’
Actnano Logo

Actnano

HQ: United States Website
  • Description: Provider of nanotechnology-based smart coatings that protect electronics and surfaces from water and harsh environmental conditions. Offerings include PFAS- and fluorine-free Advanced nanoGUARD conformal coating for full PCBA protection against moisture, humidity, condensation, salt and sweat, and durable anti-fog coatings. Serves automotive (including ADAS), consumer electronics, medical devices, solar and industrial electronics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Actnano company profile β†’
Nanostone Water Logo

Nanostone Water

HQ: United States Website
  • Description: Provider of ceramic and polymeric membrane solutions for industrial process fluid and water treatment. Offers ceramic membrane technology with fouling resistance and high permeability for applications such as municipal drinking water, seawater desalination, municipal wastewater reuse, boiler feed water for power generation, and cooling tower blowdown treatment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nanostone Water company profile β†’
Zyvex Logo

Zyvex

HQ: United States Website
  • Description: Provider of molecular nanotechnology innovations focused on developing atomically precise manufacturing. Founded in 1997 as the first molecular nanotechnology company; by 2007 its research had been commercialized into several products and it later restructured into separate companies to focus on product lines.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Zyvex company profile β†’
Shocking Technologies Logo

Shocking Technologies

HQ: United States Website
  • Description: Provider of Voltage Switchable Dielectric (VSD) materials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Shocking Technologies company profile β†’
πŸ”’

2.M&A buyers

2.1 Potential strategic acquirers in the sector

πŸ”’
πŸ”’
πŸ”’
πŸ”’ View all strategic buyers with complete profiles
Start Free Trial β†’

2.2 - Strategic buyer groups for N2 Biomedical

πŸ”’

Buyer group 1: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”’

Buyer group 2: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”’

Buyer group 3: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”“ Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β†’

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to N2 Biomedical

2.2 - Growth funds investing in similar companies to N2 Biomedical

πŸ”’ View all growth equity funds with complete profiles
Start Free Trial β†’

4 - Top valuation comps for N2 Biomedical

4.2 - Public trading comparable groups for N2 Biomedical

πŸ”“ Unlock all public trading comparable groups with complete valuation data
Start Free Trial β†’

4.3 - M&A Transactions similar to N2 Biomedical

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
πŸ”’ View all M&A transactions with complete deal terms
Request Free Trial Now β†’

Frequently Asked Questions

About N2 Biomedical

What does N2 Biomedical do?

N2 Biomedical is a provider of coating, anodizing, and printing services for medical devicesβ€”including guidewires, core wires, hypo tubes, and forming mandrelsβ€”for global healthcare and medical device companies. Collaborates from concept to commercialization, offering flexible prototype work and high-volume production.

Who are N2 Biomedical's competitors?

N2 Biomedical's competitors and similar companies include Nano-C, Actnano, Nanostone Water, Zyvex, and Shocking Technologies.

Where is N2 Biomedical headquartered?

N2 Biomedical is headquartered in United States.

How many employees does N2 Biomedical have?

N2 Biomedical has 1,000 employees πŸ”’.

When was N2 Biomedical founded?

N2 Biomedical was founded in 2010 πŸ”’.

What sector and industry vertical is N2 Biomedical in?

N2 Biomedical is in the Enterprise Software πŸ”’ sector and industry

M&A Buyers & Acquirers for N2 Biomedical

Who are the top strategic acquirers in N2 Biomedical's sector and industry

Top strategic M&A buyers and acquirers in N2 Biomedical's sector include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Which M&A buyer groups are most relevant for N2 Biomedical?

Top strategic M&A buyers groups and sectors for N2 Biomedical include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ , β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Financial Investors investing in N2 Biomedical's sector and industry vertical

Which are the top PE firms investing in N2 Biomedical's sector and industry vertical?

Top PE firms investing in N2 Biomedical's sector and industry vertical include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Who are the top buyout funds acquiring in N2 Biomedical's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in N2 Biomedical's sector and industry vertical include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Who are the top growth equity funds investing in companies in N2 Biomedical's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to N2 Biomedical include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Valuation benchmarks of companies in N2 Biomedical's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for N2 Biomedical?

The key public trading comparables and valuation benchmarks for N2 Biomedical include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Which are the key trading comparable groups for N2 Biomedical for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for N2 Biomedical with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in N2 Biomedical's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for N2 Biomedical with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in N2 Biomedical's' sector and industry vertical?

Access recent funding rounds and capital raises in N2 Biomedical's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for N2 Biomedical

Launch login modal Launch register modal